-
VRDN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Viridian Therapeutics (VRDN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm | 200.32 mm |
Cash burn (monthly) | (no burn) | (no burn) | 27.83 mm | 23.59 mm | 22.57 mm | 16.42 mm |
Cash used (since last report) | n/a | n/a | 141.41 mm | 119.86 mm | 114.69 mm | 83.42 mm |
Cash remaining | n/a | n/a | 58.91 mm | 80.45 mm | 85.63 mm | 116.90 mm |
Runway (months of cash) | n/a | n/a | 2.1 | 3.4 | 3.8 | 7.1 |
13F holders | Current |
---|---|
Total holders | 186 |
Opened positions | 43 |
Closed positions | 30 |
Increased positions | 78 |
Reduced positions | 42 |
13F shares | Current |
---|---|
Total value | 1.67 tn |
Total shares | 100.83 mm |
Total puts | 917.20 k |
Total calls | 476.80 k |
Total put/call ratio | 1.9 |
Largest owners | Shares | Value |
---|---|---|
FMR | 11.88 mm | $227.78 bn |
BlackRock | 5.76 mm | $110.39 bn |
Vanguard | 4.60 mm | $88.09 bn |
Deep Track Capital | 4.52 mm | $86.70 bn |
VR Adviser | 3.88 mm | $74.43 bn |
Venrock Healthcare Capital Partners III | 3.58 mm | $71.79 mm |
STT State Street | 3.52 mm | $67.53 bn |
Fairmount Funds Management | 3.45 mm | $66.06 bn |
Kynam Capital Management | 3.33 mm | $63.76 bn |
Tang Capital Management | 2.49 mm | $47.79 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Sep 24 | Stephen F. Mahoney | Common Stock | Buy | Acquire P | No | No | 23.33 | 21,400 | 499.26 k | 21,400 |
27 Sep 24 | Beetham Thomas W. | Common Stock | Buy | Acquire P | No | No | 23.41 | 5,000 | 117.05 k | 6,000 |
13 Sep 24 | Fairmount Funds Management | Common Stock | Buy | Acquire P | Yes | No | 18.75 | 1,600,000 | 30.00 mm | 3,445,813 |
26 Jun 24 | Harwin Peter Evan | Stock Option Common Stock | Grant | Acquire A | Yes | No | 12.31 | 21,000 | 258.51 k | 21,000 |
26 Jun 24 | Morris Arlene | Stock Option Common Stock | Grant | Acquire A | No | No | 12.31 | 21,000 | 258.51 k | 21,000 |